Key result
Extended chemoprophylaxis shows no benefit over short-term prophylaxis for VTE after DIEP flap reconstruction.
Why the study?
Does long-term chemoprophylaxis reduce venous thromboembolism in patients undergoing DIEP flap breast reconstruction compared to short-term chemoprophylaxis?
Meta-Analysis (n=1,114)
Does long-term chemoprophylaxis reduce venous thromboembolism in patients undergoing DIEP flap breast reconstruction compared to short-term chemoprophylaxis?
Answers are grounded in this paper and cite their sources.
Extending chemoprophylaxis beyond hospitalization does not significantly reduce VTE incidence or increase hematoma risk in patients undergoing DIEP flap breast reconstruction.
Venous thromboembolism (VTE) is a significant complication following deep inferior epigastric artery perforator (DIEP) flap breast reconstruction. The optimal duration of chemoprophylaxis remains debated, with differing recommendations on short-term chemoprophylaxis (STC) vs long-term chemoprophylaxis (LTC) for VTE prevention. This systematic review and meta-analysis compared the efficacy and safety of STC vs LTC in preventing VTE and hematoma in patients undergoing DIEP flap reconstruction. Four studies with a total of 1114 patients were included, with no significant differences in patient characteristics, including Caprini scores, between the STC and LTC groups. The pooled incidence of VTE was 1.83%, with 2.19% in the STC group and 1.33% in the LTC group, yielding a risk ratio (RR) of 1.42 for STC compared to LTC, although this was not statistically significant (P = .62). The mean incidence of hematoma was 8.65%, with 8.32% in the STC group and 9.02% in the LTC group, resulting in an RR of 0.78 for STC compared to LTC, which was also not statistically significant (P = .25). These findings suggest that extending chemoprophylaxis beyond hospitalization does not significantly reduce VTE incidence and underscores the importance of individualized risk-based anticoagulation strategies. Future studies are necessary to further refine guidelines for chemoprophylaxis duration in this population, balancing the risks of VTE and anticoagulation-related complications to optimize patient outcomes.
No takes yet. Share an insight, caveat, or question.
Hinson et al. (2025) conducted a meta-analysis in DIEP flap breast reconstruction (n=1,114). Short-term chemoprophylaxis (STC) vs. Long-term chemoprophylaxis (LTC) was evaluated on Venous thromboembolism (VTE) (RR 1.42, p=.62). Short-term chemoprophylaxis did not differ from long-term chemoprophylaxis in preventing VTE following DIEP flap breast reconstruction.
Synapse has enriched 10 related papers. Consider them for comparative context: